Tag - QTRX

Markets

Leerink ups Quanterix to OP; PT to $30

Leerink Partners upgraded Quanterix (NASDAQ:QTRX) to “outperform” from “market perform” and raised its price target to $30 from $25, citing strong evidence for its assays redevelopment effort. Analyst Puneet Souda...

August 8, 2023

Markets

Canaccord starts Quanterix at buy; PT $27

Canaccord Genuity initiated coverage of Quanterix (NASDAQ:QTRX) with a “buy” rating and $27 price target. The stock closed at $18.37 on Oct. 9. “We view Quanterix as a precision medicine pure-play well positioned to...

October 10, 2018

Executive Moves

Analysts start Quanterix at OP, buy; PTs $27, $26

Analysts at Leerink and BTIG launched coverage of Quanterix (NASDAQ:QTRX) with “outperform” and “buy” ratings, respectively, and price targets of $27 and $26, respectively. The stock closed at $21.47 on Dec. 29.

January 2, 2018

Tag - QTRX

Leerink ups Quanterix to OP; PT to $30

Canaccord starts Quanterix at buy; PT $27

Analysts start Quanterix at OP, buy; PTs $27, $26

General

More